01.09.1999 | REVIEW
Targeting unique tumor antigens and modulating the cytokine environment may improve immunotherapy for tumors with immune escape mechanisms
Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 7/1999
Einloggen, um Zugang zu erhalten